ADMS
Adamas Pharmaceuticals
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
77 hedge funds and large institutions have $276M invested in Adamas Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 29 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
5% less call options, than puts
Call options by funds: $453K | Put options by funds: $478K
28% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 29
Holders
77
Holding in Top 10
3
Calls
$453K
Puts
$478K
Top Buyers
| 1 | +$5.14M | |
| 2 | +$4M | |
| 3 | +$3.73M | |
| 4 |
AI
Axiom Investors
Greenwich,
Connecticut
|
+$1.76M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.1M |
Top Sellers
| 1 | -$6.73M | |
| 2 | -$5.25M | |
| 3 | -$2.77M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$2.65M |
| 5 |
BlackRock
New York
|
-$1.95M |